Inactive Instrument

News AVAX Technologies, Inc. Other OTC

Equities

Avax Technologies Announces Results of its OVAX, Ovarian Cancer Vaccine, Phase 1/2 Clinical Trial in Patients with Relapsed Stage III or IV Ovarian Cancer	16-01-26	CI
AVAX Technologies : Announces the Appointment of Chief Executive Officer	15-10-19	PR
AVAX Technologies, Inc. Appoints Adele Sommerfeld as Chief Executive Officer	15-10-19	CI
AVAX Technologies Inc. announced that it expects to receive $45 million in funding	15-08-03	CI
AVAX Technologies Inc. Announces Expansion of Clinical Study with Autologous Ovarian Cancer Vaccine Ovax	14-02-11	CI
AVAX TEC : AVAX Technologies, Inc. Closes Bridge Financing	09-12-16	PR
AVAX TECHNOLOGIES : AVAX Technologies, Inc. Announces Closing of Bridge Loan Financing	08-10-30	PR

No results for this search